☰

Guankui Wang, Ph.D. - Publications

Affiliations: 
2012 University of Idaho, Moscow, ID, United States 
Area:
Animal Physiology Biology, Pharmaceutical Chemistry, Biochemistry, Cell Biology, Nanotechnology
Tree Info Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Yang C, Chen F, Ren P, Lofchy L, Wan C, Shen J, Wang G, Gaikwad H, Ponder J, Jordan CT, Scheinman R, Simberg D. Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32682903 DOI: 10.1016/J.Jconrel.2020.07.019  0.3
2020 Gaikwad H, Li Y, Gifford G, Groman E, Banda NK, Saba L, Scheinman R, Wang G, Simberg D. Complement Inhibitors Block Complement C3 Opsonization and Improve Targeting Selectivity of Nanoparticles in Blood. Bioconjugate Chemistry. PMID 32598839 DOI: 10.1021/Acs.Bioconjchem.0C00342  0.32
2019 Gifford G, Vu VP, Banda NK, Holers VM, Wang G, Groman E, Backos D, Scheinman R, Moghimi SM, Simberg D. Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30974134 DOI: 10.1016/J.Jconrel.2019.04.009  0.328
2019 Vu VP, Gifford GB, Chen F, Benasutti H, Wang G, Groman EV, Scheinman R, Saba L, Moghimi SM, Simberg D. Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles. Nature Nanotechnology. PMID 30643271 DOI: 10.1038/S41565-018-0344-3  0.372
2018 Smith WJ, Wang G, Gaikwad H, Vu VP, Groman E, Bourne DWA, Simberg D. Accelerated Blood Clearance of Antibodies by Nanosized Click Antidotes. Acs Nano. PMID 30516974 DOI: 10.1021/Acsnano.8B07003  0.337
2017 Benasutti H, Wang G, Vu VP, Scheinman R, Groman E, Saba L, Simberg D. Variability of Complement Response toward Preclinical and Clinical Nanocarriers in the General Population. Bioconjugate Chemistry. PMID 29090582 DOI: 10.1021/Acs.Bioconjchem.7B00496  0.346
2017 Griffin JI, Wang G, Smith WJ, Vu VP, Scheinman R, Stitch D, Moldovan R, Moghimi SM, Simberg D. Revealing Dynamics of Accumulation of Systemically Injected Liposomes in the Skin by Intravital Microscopy. Acs Nano. PMID 29045127 DOI: 10.1021/Acsnano.7B06524  0.301
2017 Wang G, Griffin JI, Inturi S, Brenneman B, Banda NK, Holers VM, Moghimi SM, Simberg D. In Vitro and In Vivo Differences in Murine Third Complement Component (C3) Opsonization and Macrophage/Leukocyte Responses to Antibody-Functionalized Iron Oxide Nanoworms. Frontiers in Immunology. 8: 151. PMID 28239384 DOI: 10.3389/Fimmu.2017.00151  0.335
2016 Chen F, Wang G, Griffin JI, Brenneman B, Banda NK, Holers VM, Backos DS, Wu L, Moghimi SM, Simberg D. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. Nature Nanotechnology. PMID 27992410 DOI: 10.1038/Nnano.2016.269  0.365
2016 Wang G, Chen F, Banda NK, Holers VM, Wu L, Moghimi SM, Simberg D. Activation of Human Complement System by Dextran-Coated Iron Oxide Nanoparticles Is Not Affected by Dextran/Fe Ratio, Hydroxyl Modifications, and Crosslinking. Frontiers in Immunology. 7: 418. PMID 27777575 DOI: 10.3389/Fimmu.2016.00418  0.34
2015 Inturi S, Wang G, Chen F, Banda NK, Holers VM, Wu L, Moghimi SM, Simberg D. Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake. Acs Nano. PMID 26488074 DOI: 10.1021/Acsnano.5B05061  0.381
2015 Wang G, Simberg D. Role of Scavenger Receptors in Immune Recognition and Targeting of Nanoparticles Reviews in Cell Biology and Molecular Medicine. 1: 166-189. DOI: 10.1002/3527600906.Mcb.201500018  0.353
2014 Wang G, Inturi S, Serkova NJ, Merkulov S, McCrae K, Russek SE, Banda NK, Simberg D. High-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating properties. Acs Nano. 8: 12437-49. PMID 25419856 DOI: 10.1021/Nn505126B  0.34
2014 Gifford JC, Bresee J, Carter CJ, Wang G, Melander RJ, Melander C, Feldheim DL. Thiol-modified gold nanoparticles for the inhibition of Mycobacterium smegmatis. Chemical Communications (Cambridge, England). 50: 15860-3. PMID 25350535 DOI: 10.1039/C4Cc06236A  0.353
2014 Bresee J, Bond CM, Worthington RJ, Smith CA, Gifford JC, Simpson CA, Carter CJ, Wang G, Hartman J, Osbaugh NA, Shoemaker RK, Melander C, Feldheim DL. Nanoscale structure-activity relationships, mode of action, and biocompatibility of gold nanoparticle antibiotics. Journal of the American Chemical Society. 136: 5295-300. PMID 24624950 DOI: 10.1021/Ja408505N  0.335
2013 Wang G, Norton AS, Pokharel D, Song Y, Hill RA. KDEL peptide gold nanoconstructs: promising nanoplatforms for drug delivery. Nanomedicine : Nanotechnology, Biology, and Medicine. 9: 366-74. PMID 23041411 DOI: 10.1016/J.Nano.2012.09.002  0.687
2012 Papasani MR, Wang G, Hill RA. Gold nanoparticles: the importance of physiological principles to devise strategies for targeted drug delivery. Nanomedicine : Nanotechnology, Biology, and Medicine. 8: 804-14. PMID 22306155 DOI: 10.1016/J.Nano.2012.01.008  0.698
2012 Wang G, Papasani MR, Cheguru P, Hrdlicka PJ, Hill RA. Gold-peptide nanoconjugate cellular uptake is modulated by serum proteins. Nanomedicine : Nanotechnology, Biology, and Medicine. 8: 822-32. PMID 22051699 DOI: 10.1016/J.Nano.2011.10.007  0.623
2011 Julien DC, Behnke S, Wang G, Murdoch GK, Hill RA. Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer. Mabs. 3: 467-78. PMID 21814040 DOI: 10.4161/mabs.3.5.16089  0.623
2010 Papasani MR, Thornton K, Yinggian Z, Brezas A, Welch C, Wang G, Villasante A, Pokharel D, Cheguru P, Kotla S, Julien DC. Does obesity reduce load-induced muscle hypertrophy? The Journal of Physiology. 588: 1819-20. PMID 20516348 DOI: 10.1113/Jphysiol.2010.189357  0.611
2009 Papasani MR, Wang G, Cheguru P, Julien DC, Hofwegen DV, Chapalamadugu KC, Brooking A, Read S. Interactions of muscle regulatory factors and isoforms of insulin growth factor-1 in the muscle regenerative process. The Journal of Physiology. 587: 2427-8. PMID 19483251 DOI: 10.1113/Jphysiol.2009.169540  0.658
Show low-probability matches.